ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
GRI Bio Inc

GRI Bio Inc (GRI)

1.715
-0.025
( -1.44% )
Updated: 15:41:44

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.715
Bid
1.70
Ask
1.73
Volume
53,562
1.65 Day's Range 1.7499
0.205 52 Week Range 28.70
Previous Close
1.74
Open
1.66
Last Trade
400
@
1.715
Last Trade Time
15:41:44
Average Volume (3m)
478,562
Financial Volume
$ 90,837
VWAP
1.6959

GRI Latest News

GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series

Live video webcast on Wednesday, July 17th at 12:00 PM ET LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology...

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment

Marc Hertz, PhD, CEO of GRI Bio underscores importance of the interim data from their ongoing Phase 2a biomarker study for Idiopathic Pulmonary Fibrosis (IPF) LA JOLLA, CA, July 11, 2024 (GLOBE...

GRI Bio Regains Compliance with Nasdaq

LA JOLLA, CA, July 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...

GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine

Data demonstrates that NKT cells are activated in airways in IPF patients and inhibition of type 1 invariant NKT (iNKT) cell activity can ameliorate bleomycin-induced pulmonary fibrosis in mice...

GRI Bio to Present at the 8th Annual IPF Summit

LA JOLLA, CA, July 01, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...

GRI Bio Announces Closing of $4.0 Million Public Offering

LA JOLLA, CA, June 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...

GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators

Company is strategically building a global patent estate in key territories for a growing pipeline targeting potentially high-value indications in need of innovation LA JOLLA, CA, June 27, 2024...

GRI Bio Announces Pricing of $4 Million Public Offering

LA JOLLA, CA, June 27, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0754.573170731711.641.93991.513984911.74146472CS
41.481632.9059829060.2343.490.20554941081.71394243CS
121.1982231.8498452010.51683.490.2054785620.77858818CS
26-0.49-22.22222222222.20550.2056190401.26980888CS
52-26.005-93.813131313127.7228.70.2054415322.8170569CS
156-90.685-98.143939393992.493.310.2053646393.46274113CS
260-90.685-98.143939393992.493.310.2053646393.46274113CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SHOTWSafety Shot Inc
$ 0.41
(115.79%)
7.56k
AMIXAutonomix Medical Inc
$ 1.3288
(115.02%)
150.3M
DATSDatChat Inc
$ 1.67
(60.58%)
52.23M
SCNIScinai Immunotherapeutics Ltd
$ 5.79
(42.61%)
28.89M
CYNCYNGN Inc
$ 8.4393
(41.36%)
16.54M
ASLNASLAN Pharmaceuticals Ltd
$ 1.42
(-44.31%)
1.08M
LCFYLocafy Ltd
$ 3.5992
(-35.61%)
519.53k
NAASNaaS Technology Inc
$ 2.7599
(-34.44%)
1.81M
KZIAKazia Therapeutics Ltd
$ 0.589419
(-34.20%)
13.3M
LXEOLexeo Therapeutics Inc
$ 13.00
(-26.14%)
2.05M
FFIEFaraday Future Intelligent Electric Inc
$ 0.5062
(19.95%)
186.02M
NVDANVIDIA Corporation
$ 128.05
(-0.92%)
176.19M
AMIXAutonomix Medical Inc
$ 1.3288
(115.02%)
150.3M
SQQQProShares UltraPro Short QQQ
$ 7.4299
(-1.07%)
138.38M
TSLATesla Inc
$ 255.12
(2.78%)
126.92M

Your Recent History

Delayed Upgrade Clock